ARQIS has advised ArchiMed on the acquisition of Germany’s Zyto Group of cancer diagnostics companies in partnership with owners and management. With ArchiMed’s backing, the group is expected to rapidly become a European leader in diagnostics for cutting-edge, precision medical treatments for cancer.
ArchiMed is acquiring a majority stake in the group through its MED II fund, which closed on 315 million euros in 2017. MED II buys control of small cap healthcare companies in partnership with existing owners and staff. The founders and managers of the Zyto companies will have a significant minority shareholding in the group and will benefit from performance incentives post-transaction.
“Our internal expertise – a majority of ArchiMed team members have science backgrounds and many have operational experience in medical or pathology labs – was key to understanding the potential of Zyto’s complex, industry-leading products,” says ArchiMed managing partner Vincent Guillaumot. “With our backing, these companies have the resources for further product innovation and for rapid international expansion. Our aim is to bring new precision diagnostics to rare diseases such as lymphoma and leukemia.”
ArchiMed is an independent investment firm specialized in the Healthcare industries and has over 1.7 billion euros under management across three funds, mid-cap-focused MED Platform I, and small-cap-focused MED I and MED II.
The ARQIS team around partner Dr. Jörn-Christian Schulze was recommended to ArchiMed in 2019 and advised the investor a second time now.
Advisors to ArchiMed
ARQIS Rechtsanwälte (Düsseldorf): Dr. Jörn-Christian Schulze (Lead), Dr. Lars Laeger (both Transactions), Tobias Neufeld (Data.Law), Johannes Landry (Finance), Dr. Ulrich Lienhard (Real Estate), Marcus Nothhelfer (IP/IT; Munich); Counsel: Thomas Chwalek (Transactions), Dr. Stephanie Lenze (HR.Law), Sina Janke (Compliance); Associates: Carolin Schlütter-Lückel, Kamil Flak, Dr. Nima Hanifi-Atashgah, Malte Griepenburg (all Transactions), Eva Kraszkiewicz, Thi Kieu Chinh Nguyen (both HR.Law), Diana Puchowezki (Real Estate), Nora Meyer-Stratmann (IP/IT; Munich), Berenike Gottwald (Legal Specialist/HR.Law)